Key Highlights
- Anyone scanning the regulatory feed for Intertek Group plc (LSE:ITRK) finds an unusually thick seam of Takeover Code filings. Form 8.3 dealing disclosures arrive daily from index managers, arbitrage desks and long-only holders, alongside Form 8.5 filings from exempt principal traders.
- Intertek provides testing, inspection and certification: the assurance work behind product safety, Supply chain audit and regulatory compliance, competing with SGS, Bureau Veritas and Eurofins.
The Paperwork Is Noise; the Deal Is Not
Anyone scanning the regulatory feed for Intertek Group plc (LSE:ITRK) finds an unusually thick seam of Takeover Code filings. Form 8.3 dealing disclosures arrive daily from index managers, arbitrage desks and long-only holders, alongside Form 8.5 filings from exempt principal traders.
That Volume is easy to misread as a market still guessing. A Form 8.3 is a dealing disclosure required of any person interested in one % or more of a class of relevant securities during an offer period. It records trades; it neither announces nor signals a bid. The filings exist because Intertek has been in an Offer Period since the spring, and the offer at its centre became firm three months ago.
What EQT Actually Agreed to Pay
On 18 June 2026 Intertek published a Rule 2.7 announcement of a recommended final cash offer from Isotope Bidco Limited, a vehicle indirectly owned by the EQT X funds, with minority participation from Luxinva and Mubadala.
Shareholders are to receive £60.00 in cash per share and retain the 107.7 pence final Dividend for the 2025 financial year in full, taking the aggregate value to £61.077 per share. The announcement put Equity value at approximately £9.5bn and Enterprise value at approximately £10.9bn. Press estimates circulating before the firm offer had pitched the transaction nearer £9.2bn to £9.3bn; those were pre-announcement figures, and the offer document's numbers are the ones that govern.
The premium was struck at 62% to the £37.70 closing price on 9 April 2026 and 64% to the preceding one-month volume-weighted average of £37.18. Because the offer was declared final, EQT is bound by that statement unless a competing bid emerges.
The Vote, and What It Settled
The transaction is structured as a court-sanctioned scheme of arrangement under Part 26 of the Companies Act, with a right to switch to a contractual takeover offer. The scheme document was posted on 15 July 2026 and the Court Meeting and General Meeting were held on 6 August 2026.
Approval was emphatic. At the Court Meeting, 82,888,264 shares were voted in favour against 1,077,706 opposed, or 98.72% by value, carried by 62 shareholders voting in favour and 14 against. The special resolution at the General Meeting passed on the same margin.
What the vote did not do is complete the deal. The scheme becomes effective only when the court sanction order is delivered to Companies House, and sanction depends on antitrust and foreign Investment clearances across several jurisdictions. Intertek's guidance is that the sanction hearing and effective date fall in the fourth quarter of 2026 or the first quarter of 2027, with a long stop date of 18 June 2027.
Trading Through the Offer
Intertek has kept performing while the process runs. Half-year results on 31 July 2026 showed Revenue of £1,771.3m, up 5.9%, with like-for-like revenue growth of 4.9% at constant currency. Adjusted operating profit rose 12.4% at constant currency to £309.7m, lifting the adjusted operating Margin 100 basis points to 17.5%, and adjusted Diluted Earnings per Share reached 124.9 pence.
Free Cash Flow of £138.5m was £82.5m higher year on year, and net financial Debt stood at £1,145.5m, or 1.4 times EBITDA. No Interim Dividend was proposed, consistent with the dividend restrictions in the offer terms. Full-year guidance is for mid-single-digit like-for-like revenue growth at constant currency.
Why a Testing Business Attracts This Capital
Intertek provides testing, inspection and certification: the assurance work behind product safety, supply chain audit and regulatory compliance, competing with SGS, Bureau Veritas and Eurofins. Recurring revenue, embedded customer relationships and regulatory Demand suit long-hold institutional capital, which is why the sector has consolidated repeatedly.
For London, the departure of another FTSE 100 constituent to overseas private Capital extends a well-documented pattern. For holders, the open questions are clearance timing and the closing date, not price.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...